Coronary artery disease Posts on Medivizor
Navigation Menu

Coronary artery disease Posts on Medivizor

Bioabsorbable versus permanent stents – what are the long-term clinical benefits?

Posted by on Jun 16, 2019 in Coronary artery disease | 0 comments

In a nutshell This study investigated if bioabsorbable polymer (BP) or permanent polymer (PP) drug-eluting stents (DES) are more effective. They found that BP- and PP-DES are similarly effective. Some background Coronary artery disease (CAD) is a common and serious condition. It leads to blockages in the coronary arteries that supply blood to the...

Read More

No Salt, Please

No Salt, Please

Posted by on Jun 8, 2019 in Blog, Coronary artery disease, Hypertension, Stroke | 0 comments

A recent commentary in the New England Journal of Medicine describes what is really happening with the US food supply. In 2010, a report by the Institute of Medicine (IOM–now called the National Academy of Medicine) stated that, salt intake is actually a factor that is out of our personal control. This is because only 5% of sodium is coming from the...

Read More

Drug-eluting stent vs bypass grafting in diabetic patients with coronary artery disease

Posted by on Jun 4, 2019 in Coronary artery disease | 0 comments

In a nutshell This article investigated the safety and effectiveness of percutaneous coronary intervention with drug-eluting stent (PCI-DES) vs coronary artery bypass graft (CABG) for patients with diabetes mellitus (DM).  The authors concluded that CABG was better than PC-DES in these patients.  Some background DM is a disorder where the...

Read More

The effect of invasive management in elderly patients after a heart attack

Posted by on May 30, 2019 in Coronary artery disease | 0 comments

In a nutshell This article investigated the safety and effectiveness of invasive treatment in the management of patients that had an ST-elevation myocardial infarction (STEMI; heart attack). The authors concluded that invasive treatment caused lower adverse events in older high-risk patients.  Some background Multimorbidity (MM) is the...

Read More

Does metformin treatment improve heart enlargement in coronary artery disease?

Posted by on May 30, 2019 in Coronary artery disease | 0 comments

In a nutshell This study investigated if metformin (Glucophage) improves left ventricular hypertrophy (LVH; enlargement of the left lower chamber of the heart) in coronary artery disease (CAD). They found that this treatment improved LVH and other CAD symptoms.  Some background Coronary artery disease (CAD) is a disease of the arteries supplying...

Read More

Psychological distress and cardiovascular events – is there a link?

Posted by on May 26, 2019 in Coronary artery disease | 0 comments

In a nutshell This study investigated the effect of psychological distress (PSD) on cardiovascular events (CVEs) in patients with coronary artery disease (CAD).  They found that PSD was associated with higher CVE rates in women only.  Some background Mental health disorders are an increasing health problem worldwide. These include anxiety...

Read More

Does chronic use of beta-blockers increase the risk of developing Parkinson’s disease?

Posted by on May 18, 2019 in Coronary artery disease | 0 comments

In a nutshell This article investigated the association between chronic (long-term) exposure to beta-blockers (BBs) with an increased risk for Parkinson’s disease (PD). The authors concluded that the chronic use of BBs is associated with an increased risk for PD. Some background In PD, certain nerve cells (neurons) in the brain...

Read More

The association between the inflammatory marker CRP, vitamin D levels and heart disease

Posted by on May 17, 2019 in Coronary artery disease | 0 comments

In a nutshell The aim of this study was to investigate the association between C-reactive protein (CRP; a marker of inflammation), vitamin D and cardiovascular disease (CVD). The main finding of the study was that high CRP levels and low vitamin D levels in the blood were associated with CVD. Some background CVD is a leading cause of death worldwide....

Read More

Supraflex: A new ultra-thin drug releasing stent for patients with coronary artery disease

Posted by on May 11, 2019 in Coronary artery disease | 0 comments

In a nutshell The aim of this study was to compare Supraflex (a new ultra-thin drug releasing stent) with a standard drug releasing stent (Xience) in the treatment of coronary artery disease (CAD). The main finding of the study was that the Supraflex had similar effectiveness as Xience. Some background CAD means that the blood vessels to the...

Read More